TGA Approval

SPRAVATO esketamine (as hydrochloride) 28 mg per 2 actuations nasal spray solution (311827)

ARTG ID

311827

ARTG Name

SPRAVATO esketamine (as hydrochloride) 28 mg per 2 actuations nasal spray solution

Sponsor

Janssen-Cilag Pty Ltd

ARTG Date

March 9, 2021

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

JANSSEN-CILAG PTY LTD

https://medical-cdn.nocode.com/drug_tga/effe1927676a80364ae20240fb6f475b.pdf

https://medical-cdn.nocode.com/drug_tga/16b3cf744f282c206fa3bfe08dd3bc45.pdf

Ingredient Name

esketamine hydrochloride

Empowering clinical research with data-driven insights and AI-powered tools.

SPRAVATO esketamine (as hydrochloride) 28 mg per 2 actuations nasal spray solution (311827) - TGA 批准文号 | MedPath